Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Montevialeon Aug 31, 2017 1:15pm
204 Views
Post# 26643025

TSX has no legal grounds to suspend or delist Aphria.

TSX has no legal grounds to suspend or delist Aphria.
Interesting to note that the TSXV and the TSX have different listing requirements that they must comply with.   

The TSXV’s Listing Agreement requires that a listed issuer agree to comply with all laws, rules and regulations applicable to its business or undertaking, although the TSX’s Listing Agreement does not contain such language. 

TSXV Listing Agreement

TSX Listing Agreement

In fact, no aspect of the TSX’s Company Manual actually specifies that issuers must comply with the laws of their jurisdictions, although section 701 of the Manual states that the TSX may suspend or delist an issuer if “such action is necessary in the public interest”.  

Section 701 of Manual

TMX spokeswoman Catherine Kee has said that the Exchange mandates that all listed companies are expected to comply with relevant laws and regulations in the jurisdictions in which they operate, and that “each issuer is handled on a fact-specific basis”.

The test for suspending or delisting an issuer listed on the TSX is whether "such action is necessary in the public interest".  Thats why TMX has issued a statement that each case case is handled on a fact-specific basis.  

IMO the chances of Aphria being suspended or delisted is zero.  There are those that would argue that such acion is necessary in the public interest, (anyone can argue anything), however the case for such argument is weak at best.

In the unlikely event that the TSX ever did decide against Aphria, the decsion would IMO be overturned in the courts. 

This is why Lou Eccleston CEO of TMX has come out and confirmed that the TMX Group does not expect to issue a cannabis specific listing policy.  You can't retroacively draft a policy and then rely on it to suspend or delist a compnay.  Worst case scenario is you draft a polciy that pertains to future listings and grandfathers in those companies already listed on the TSX.  

The only issue to be reolved is the CDS and although I've made  my opinion clear in previous posts, I will deal with the CDS in one final post at a later date.  

M

 
Bullboard Posts